Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning

Glucose Metabolism Clinical Trial

Official title:

Effect of Feeding Frequency on Glucose and Insulin Metabolism and Substrate Partitioning

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01034293
• Other study ID #: MEC 09-3-032
• Status: Completed
• Phase: N/A
• First received: December 16, 2009
• Last updated: July 22, 2010
• Start date: October 2009
• Est. completion date: June 2010

Study information

• Verified date: July 2010
• Source: Maastricht University Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine the effect of feeding frequency on glucose and insulin metabolism and substrate partitioning.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: June 2010
• Est. primary completion date: March 2010
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• BMI: 18.5-25 kg/m2 (lean)

• Gender: Male

• Age: subjects has to be older than 18 and including 35 years old

• Caucasian

Exclusion Criteria:

• Metabolic abnormalities such as:

1. Lactose intolerant

2. Diabetes Mellitus

3. Hypertension

4. Hypotension

5. Cardiovascular diseases

6. Asthma and other obstructive pulmonary diseases

7. Elevated fasting blood glucose level

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Glucose Metabolism
• Insulin

Intervention

Dietary Supplement:
• low feeding frequency (3x)
3 meals a day
• High feeding frequency (14x)
14 meals a day

Locations

Country	Name	City	State
Netherlands	University of Maastricht	Maastricht	Limburg

Sponsors (2)

Lead Sponsor	Collaborator
Maastricht University Medical Center	Nederlandse Zuivel Organisatie

Country where clinical trial is conducted

Netherlands, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Glucose and insulin metabolism		24 h	No
Secondary	Substrate partitioning and metabolic markers		24 h	No